ANTM News and Press, Anthem Inc. From 10/08/20

The S&P 500 is up 7% from its recent lows, and once more in a speculative bubble. Fortunately, even for growth-hungry long-term investors, quality blue chips are always on sale. Anthem is a 9/11 quality blue chip that's 9% undervalued and analysts expect 18% CAGR long-term tot...

UnitedHealth has been a great growth investment in the past. Its valuation has expanded towards a normal level now. There are some headwinds, which is why we are moving to a more neutral stance. For further details see: Why We Are Changing Our Rating On UnitedHealth

Documentary focuses on addressing social determinants of health through gardening curriculum in the classroom for students Film also selected as nominee for ‘Indiana Spotlight’ as Holy Angels Catholic School in Indianapolis and Moores Hill in Dearborn Cou...

Anthem is adapting well to the current environment and has seen membership growth. The company has a number of growth drivers, which includes the growing senior population and cost-savings from the increased adoption of telemedicine. The shares are attractively valued, especially ...

Anthem ([[ANTM]] +2.6%) agrees to another multimillion-dollar settlement over a cyberattack on its technology that exposed the personal information of nearly 79M people.The Blue Cross-Blue Shield insurer said Wednesday that it will pay $39.5 million to settle an investigation by a g...

Anthem announced today that it has reached a settlement with the group of State Attorneys General investigating the company’s cyber-attack that occurred back in 2015, in which it was a victim of a sophisticated state sponsored criminal attack group. Anthem cooperated with the Sta...

Subsequent to PE Hub reporting that Anthem (ANTM) is believed to be in late-stage talks to acquire Connecticut-based CareCentrix, Stephens analyst Scott Fidel re-affirmed its Overweight rating (PT, $330).CareCentrix, backed by private equity firm Summit Partners, provides ...

Several of CVS's segments could be considered "mature," which has not historically been good for returns. The long-term benefits from its vertical integration strategy of acquiring Aetna have likely not been fully realized. Wall Street seems to be pricing CVS so low, to expect dec...

A simplified analysis of unicorns and SPACs leads to some interesting observations. Warrants of cannabis-focused SPACs and Acamar Partners Acquisition Corp. continue to stand out on a relative value basis. Warrants of CHP Merger Corp. appear to be mispriced when comparing with its...

The beauty of investing is that if you start early enough and buy shares of companies with decent long-term prospects, compounding can do most of the heavy lifting when it comes to building your nest egg. Indeed, even a person of modest means can reach millionaire status by retirement by picki...